on 18 Apr 2024
Last Applicant/ Owned by
51 Moulton Street
Cambridge
MA
02138
Serial Number
97773407 filed on 30th Jan 2023
Registration Number
N/A
Correspondent Address
Emilia F. Cannella ROPES & GRAY LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and T-cell based therapeutics Pharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and biological preparations based on genRead More
Pharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and T-cell based therapeutics
11th 000101
11th 000101
Pharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics for the treatment of cancer and autoimmune diseases; pharmaceutical preparations, namely, T-cell based therapeutics to treat cancer and autoimmune disease
11th 000101
11th 000101
No 97773407
No Service Mark
No 117420-T-001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st May 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Apr 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 05th Apr 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 05th Apr 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 05th Apr 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 12th Jan 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 12th Jan 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 26th Oct 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 26th Oct 2023 | NON-FINAL ACTION E-MAILED |
| 26th Oct 2023 | NON-FINAL ACTION WRITTEN |
